A detailed history of Thoroughbred Financial Services, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Thoroughbred Financial Services, LLC holds 19,914 shares of ABT stock, worth $2.29 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
19,914
Previous 19,922 0.04%
Holding current value
$2.29 Million
Previous $2.07 Million 9.66%
% of portfolio
0.15%
Previous 0.14%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$100.07 - $118.13 $800 - $945
-8 Reduced 0.04%
19,914 $2.27 Million
Q2 2024

Aug 08, 2024

BUY
$100.73 - $112.44 $189,573 - $211,612
1,882 Added 10.43%
19,922 $2.07 Million
Q1 2024

May 07, 2024

SELL
$109.52 - $120.96 $292,418 - $322,963
-2,670 Reduced 12.89%
18,040 $2.05 Million
Q4 2023

Feb 09, 2024

SELL
$90.19 - $110.4 $56,909 - $69,662
-631 Reduced 2.96%
20,710 $2.28 Million
Q3 2023

Nov 08, 2023

BUY
$95.53 - $114.62 $50,153 - $60,175
525 Added 2.52%
21,341 $2.07 Million
Q2 2023

Aug 03, 2023

SELL
$100.78 - $112.29 $9,070 - $10,106
-90 Reduced 0.43%
20,816 $2.27 Million
Q1 2023

Apr 24, 2023

SELL
$96.86 - $114.01 $73,613 - $86,647
-760 Reduced 3.51%
20,906 $2.12 Million
Q4 2022

Feb 07, 2023

BUY
$95.06 - $111.52 $72,245 - $84,755
760 Added 3.64%
21,666 $2.38 Million
Q3 2022

Oct 27, 2022

SELL
$96.76 - $112.03 $96 - $112
-1 Reduced -0.0%
20,906 $2.02 Million
Q2 2022

Aug 03, 2022

SELL
$102.07 - $123.37 $55,321 - $66,866
-542 Reduced 2.53%
20,907 $2.27 Million
Q1 2022

May 04, 2022

BUY
$114.02 - $139.04 $804,867 - $981,483
7,059 Added 49.05%
21,449 $2.54 Million
Q4 2021

Feb 09, 2022

BUY
$115.53 - $141.46 $154,694 - $189,414
1,339 Added 10.26%
14,390 $2.03 Million
Q3 2021

Oct 27, 2021

BUY
$116.66 - $129.06 $9,449 - $10,453
81 Added 0.62%
13,051 $1.54 Million
Q2 2021

Jul 27, 2021

BUY
$105.79 - $124.53 $45,807 - $53,921
433 Added 3.45%
12,970 $1.5 Million
Q1 2021

Apr 30, 2021

BUY
$108.84 - $128.23 $135,070 - $159,133
1,241 Added 10.99%
12,537 $1.5 Million
Q4 2020

Jan 26, 2021

BUY
$105.0 - $114.42 $19,845 - $21,625
189 Added 1.7%
11,296 $1.24 Million
Q3 2020

Oct 28, 2020

SELL
$91.64 - $111.29 $9,255 - $11,240
-101 Reduced 0.9%
11,107 $1.21 Million
Q2 2020

Jul 20, 2020

SELL
$76.57 - $98.0 $449,772 - $575,652
-5,874 Reduced 34.39%
11,208 $1.03 Million
Q1 2020

Apr 23, 2020

BUY
$62.82 - $91.86 $21,924 - $32,059
349 Added 2.09%
17,082 $1.35 Million
Q4 2019

Feb 05, 2020

SELL
$78.51 - $87.4 $10,206 - $11,362
-130 Reduced 0.77%
16,733 $1.45 Million
Q3 2019

Nov 12, 2019

BUY
$81.84 - $88.74 $16,449 - $17,836
201 Added 1.21%
16,863 $1.41 Million
Q2 2019

Jul 16, 2019

SELL
$72.88 - $85.0 $101 Million - $118 Million
-1,384,620 Reduced 98.81%
16,662 $0
Q2 2019

Jul 16, 2019

BUY
$72.88 - $85.0 $101 Million - $118 Million
1,385,303 Added 8669.52%
1,401,282 $0
Q1 2019

May 07, 2019

SELL
$66.22 - $80.06 $5,165 - $6,244
-78 Reduced 0.49%
15,979 $1.28 Million
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $1.05 Million - $1.19 Million
16,057 New
16,057 $1.16 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Thoroughbred Financial Services, LLC Portfolio

Follow Thoroughbred Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thoroughbred Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thoroughbred Financial Services, LLC with notifications on news.